Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit. [electronic resource]
Producer: 20100309Description: 174-80 p. digitalISSN:- 1365-2125
- Acetates -- administration & dosage
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Calcium Channels -- metabolism
- Cyclopentanes -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Kidney Diseases -- drug therapy
- Male
- Metabolic Clearance Rate -- drug effects
- Middle Aged
- Phosphodiesterase Inhibitors -- metabolism
- Reference Values
- Regression Analysis
- Severity of Illness Index
- Sleep Initiation and Maintenance Disorders -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.